Advertisement
Screener

Denali Therapeutics Inc. (DNLI) Derivative Liability

2.8 / 5 stars · 68/120 Roast Me

Denali Therapeutics Inc. Derivative Liability

Denali Therapeutics Inc. (DNLI) had Derivative Liability of $44.00 thousand as of 2022-03-31, per its 10-Q filed 2022-05-05.

Discontinued › Balance Sheet › Liabilities

us-gaap:DerivativeLiabilities · last filed 2023-02-27

  • 2022-03-31: Derivative Liability $44.00K.
  • 2021-12-31: Derivative Liability $111.00K.
  • 2021-09-30: Derivative Liability $201.00K.
  • 2021-06-30: Derivative Liability $164.00K.
Period endDerivative Liability
2022-03-31$44.00K
10-Q · filed 2022-05-05
2021-12-31$111.00K
10-K · filed 2023-02-27
2021-09-30$201.00K
10-Q · filed 2021-11-04
2021-06-30$164.00K
10-Q · filed 2021-08-04
2021-03-31$176.00K
10-Q · filed 2021-05-05
2020-12-31$11.00K
10-K · filed 2022-02-28
2020-09-30$173.00K
10-Q · filed 2020-11-05
2020-06-30$108.00K
10-Q · filed 2020-08-07
2020-03-31$141.00K
10-Q · filed 2020-05-07
2019-12-31$8.00K
10-K · filed 2021-02-26
2019-09-30$229.00K
10-Q · filed 2019-11-06
2019-06-30$155.00K
10-Q · filed 2019-08-06
2019-03-31$159.00K
10-Q · filed 2019-05-08
2018-12-31$182.00K
10-K · filed 2020-02-27
2018-09-30$123.00K
10-Q · filed 2018-11-08
2018-06-30$31.95K
10-Q · filed 2018-08-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tarsus Pharmaceuticals, Inc. (TARS)United States$3.329B-58.60
Relay Therapeutics, Inc. (RLAY)United States$3.884B-14.30
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Greenland Mines Ltd (GRML)United States$2.362B
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Adaptive Biotechnologies Corp (ADPT)United States$4.719B-53.43